| Trial ID: | L0805 |
| Source ID: | NCT03377140
|
| Associated Drug: |
Hesperidin
|
| Title: |
Evaluation of the Effects of Hesperidin Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid Profile, Blood Glucose, Insulin Sensitivity, and Hepatic Steatosis Grade in Patients With Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Steatohepatitis;Non Alcoholic Steatohepatitis;Non Alcoholic Steatohepatitis;Non Alcoholic Steatohepatitis
|
| Interventions: |
Dietary Supplement: Hesperidin;Other: control;Dietary Supplement: Hesperidin;Other: control;Dietary Supplement: Hesperidin;Other: control;Dietary Supplement: Hesperidin;Other: control
|
| Outcome Measures: |
liver fibrosis;liver fibrosis;liver fibrosis;liver fibrosisbody mass index
|
| Sponsor/Collaborators: |
National Nutrition and Food Technology Institute
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
08/12/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
8 January 2018
|
| Locations: |
Iran, Islamic Republic of;Iran, Islamic Republic of;Iran, Islamic Republic of;Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03377140
|
